Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients

Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved rapidly, leading to viral lineages characterized by multiple mutations in the spike protein, which could potentially confer to the virus the ability to avoid the vaccine-induced immune response, making the vaccines less effecti...

Full description

Bibliographic Details
Main Authors: Fabrizia Valleriani, Elisa Mancuso, Giacomo Vincifori, Liana Teodori, Lisa Di Marcantonio, Massimo Spedicato, Alessandra Leone, Giovanni Savini, Daniela Morelli, Barbara Bonfini, Alessio Lorusso
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Viruses
Subjects:
SARS-CoV-2
neutralization
viruses
variants
cells
B.1.617.2 (Delta) variant
Online Access:https://www.mdpi.com/1999-4915/13/10/2011

Internet

https://www.mdpi.com/1999-4915/13/10/2011

Similar Items